MSE
BIO icon

MUFG Securities EMEA’s Bio-Rad Laboratories Class A BIO Stock Holding History

MUFG Securities EMEA’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,000
Closed -$2.71M – 389
2020
Q2 		$2.71M Sell
6,000
-16,700
-74% -$7.37M 0.02% 265
2020
Q1 		$7.96M Buy
22,700
+8,700
+62% +$3.2M 0.08% 164
2019
Q4 		$5.18M Buy
+14,000
New +$4.94M 0.04% 270
2019
Q2 		– Sell
-13,000
Closed -$3.97M – 392
2019
Q1 		$3.97M Buy
+13,000
New +$3.51M 0.05% 230

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

MUFG Securities EMEA's BIO Position: Q3 2020 in Review

MUFG Securities EMEA sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2020, closing a stake of 6,000 shares — an estimated $2.71M sold.

MUFG Securities EMEA first reported a position in BIO in Q1 2019 and held it in 4 quarters. The position peaked at $7.96M in Q1 2020. 479 funds tracked by Wall St. Rank hold BIO as of Q3 2020.

  • MUFG Securities EMEA reported no remaining Bio-Rad Laboratories Class A position as of Q3 2020 after selling out during the quarter.
  • MUFG Securities EMEA sold 6,000 Bio-Rad Laboratories Class A shares in Q3 2020, an estimated $2.71M.
  • MUFG Securities EMEA first reported a position in Bio-Rad Laboratories Class A in Q1 2019 and held it in 4 quarters.
  • MUFG Securities EMEA's Bio-Rad Laboratories Class A position peaked at $7.96M in Q1 2020.
  • 479 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2020.

Based on MUFG Securities EMEA's 13F filing for Q3 2020, filed 13 Nov 2020.